Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5251-5258

  Castilla, Joaquín ^a   Sola, Isabel ^a   Enjuanes, Luis ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CORONAVIRUS; EPITHELIUM CELL; GENE THERAPY; IMMUNOGLOBULIN GENE; NONHUMAN; PRIORITY JOURNAL; SWINE; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS INTERFERENCE; VIRUS NEUTRALIZATION;

EID: 0030910843     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5251-5258.1997     Document Type: Article

References (50)

1. Antón, I. M., C. Suñé, R. H. Meloen, F. Borrás-Cuesta, and L. Enjuanes. 1995. A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis of the three major structural viral proteins. Virology 212:746-751.
2. Armstrong, S. J., M. C. Outlaw, and N. J. Dimmock. 1990. Morphological studies of neutralization of influenza virus by IgM. J. Gen. Virol. 71:2313-2319.
3. Biocca, S., P. Pierandrei-Amaldi, N. Campioni, and A. Cattaneo. 1994. Intracellular immunization with cytosolic recombinant antibodies. Biotechnology 12:396-399.
4. Boehringer GmbH. 1994. Boehringer manual. Boehringer GmbH, Mannheim, Germany.
5. Brim, T. A., J. L. VanCott, J. K. Lunney, and L. J. Saif. 1994. Lymphocyte proliferation responses of pigs inoculated with transmissible gastroenteritis virus or porcine respiratory coronavirus. Am. J. Vet. Res. 55:494-501.
6. Bullido, M. J., I. Correa, G. Jiménez, C. Suñé, F. Gebauer, and L. Enjuanes. 1989. Induction of transmissible gastroenteritis coronavirus-neutralizing antibodies in vitro by virus-specific T helper cell hybridomas. J. Gen. Virol. 70: 659-672.
7. Carlson, J. R. 1993. A new use for intracellular antibody expression: inactivation of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:7427-7428.
8. Correa, I., F. Gebauer, M. J. Bullido, C. Suñé, M. F. D. Baay, K. A. Zwaagstra, W. P. A. Posthumus, J. A. Lenstra, and L. Enjuanes. 1990. Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J. Gen. Virol. 71:271-279.
9. Correa, I., G. Jiménez, C. Suñé, M. J. Bullido, and L. Enjuanes. 1988. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus. Virus Res. 10:77-94.
10. De Diego, M., F. Rodriguez, C. Alcaraz, N. Gómez, C. Alonso, and J. M. Escribano. 1994. Characterization of the IgA and subclass IgG responses to neutralizing epitopes after infection of pregnant sows with the transmissible gastroenteritis virus or the antigenically related porcine respiratory coronavirus. J. Gen. Virol. 67:1405-1418.
11. Delmas, B., and H. Laude. 1990. Assembly of coronavirus spike protein into trimers and its role in epitope expression. J. Virol. 64:5367-5375.
12. Dimmock, N. J. 1993. Neutralization of animal viruses. Springer-Verlag, Heidelberg, Germany.
13. Duan, L., O. Bagasra, M. A. Laughlin, J. W. Oakes, and R. J. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad. Sci. USA 91:5075-5079.
14. Enjuanes, L., and B. A. M. van der Zeijst. 1995. Molecular basis of transmissible gastroenteritis virus epidemiology, p. 337-364. In S. G. Siddell (ed.), The coronaviridae. Plenum Press, New York, N.Y.
15. Fichot, O., and M. Girard. 1990. An improved method for sequencing of RNA templates. Nucleic Acids Res. 18:6162.
16. Fujinami, R. S., and M. B. A. Oldstone. 1984. Antibody initiates virus persistence: immune modulation and measles virus infection, p. 187-193. In A. L. Notkins and M. B. A. Oldstone (ed.), Concepts in viral pathogenesis. Springer-Verlag, New York, N.Y.
17. Gebauer, F., W. A. P. Posthumus, I. Correa, C. Suñé, C. M. Sánchez, C. Smerdou, J. A. Lenstra, R. Meloen, and L. Enjuanes. 1991. Residues involved in the formation of the antigenic sites of the S protein of transmissible gastroenteritis coronavirus. Virology 183:225-238.
18. Goodman, J. W., and J. J. Donch. 1965. Phage-neutralizing activity in light polypeptide chains of rabbit antibody. Immunochemistry 2:351-357.
19. Jiang, W., K. Venugopal, and E. A. Gould. 1995. Intracellular interference of tick-borne flavivirus infection by using a single-chain antibody. J. Virol. 69: 1044-1049.
20. Jiménez, G., I. Correa, M. P. Melgosa, M. J. Bullido, and L. Enjuanes. 1986. Critical epitopes in transmissible gastroenteritis virus neutralization. J. Virol. 60:131-139.
21. Kabat, E. A. 1982. Antibody diversity versus antibody complementarity. Pharmacol. Rev. 34:23-38.
22. Lamm, M. E., J. G. Nedrud, C. S. Kaetzel, and M. B. Mazanec. 1995. IgA and mucosal defense. APMIS 103:241-246.
23. Liew, F. Y., S. M. Russell, G. Appleyard, C. M. Brand, and J. Beale. 1984. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:350-356.
24. Liu, Y. A., W. P. Mack, C. I. Champion, and R. R. Robinson. 1987. Expression of mouse: human immunoglobulin heavy chain cDNA in lymphoid cells. Gene 54:33-40.
25. Marasco, W. A., W. A. Haseltine, and S. Chen. 1993. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA 90:7889-7893.
26. Mazanec, M. B., C. L. Coudret, and D. R. Fletcher. 1995. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69:1339-1343.
27. Mazanec, M. B., C. S. Kaetzel, M. E. Lamm, D. Fletcher, and J. G. Nedrud. 1992. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89:6901-6905.
28. Mazanec, M. B., J. G. Nedrud, C. S. Kaetzel, and M. E. Lamm. 1993. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 14:430-434.
29. McClurkin, A. W., and J. O. Norman. 1966. Studies on transmissible gastroenteritis of swine. II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis. Can. J. Comp. Med. Vet. Sci. 30:190-198.
30. McGhee, J. R., J. Mestecky, C. O. Elson, and H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175-199.
31. Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
32. Outlaw, M. C., and N. J. Dimmock. 1990. Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin. J. Gen. Virol. 71:69-76.
33. Potter, H., L. Weir, and P. Leder. 1984. Enhancer-dependent expression of human k immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81:7161-7165.
34. Richardson, J. H., and W. A. Marasco. 1995. Intracellular antibodies: development and therapeutic potential. Trends Biotechnol. 13:306-310.
35. Saif, L. J., and R. D. Wesley. 1992. Transmissible gastroenteritis, p. 362-386. In A. D. Leman, B. E. Straw, W. L. Mengeling, S. D'Allaire, and D. J. Taylor (ed.), Diseases of swine. Wolfe Publishing Ltd, Ames, Iowa.
36. Sánchez, C. M., F. Gebauer, C. Suñé, A. Méndez, J. Dopazo, and L. Enjuanes. 1992. Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology 190:92-105.
37. Sánchez, C. M., G. Jiménez, M. D. Laviada, I. Correa, C. Suñé, M. J. Bullido, F. Gebauer, C. Smerdou, P. Callebaut, J. M. Escribano, and L. Enjuanes. 1990. Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 174:410-417.
38. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
39. Sola, I., J. Castilla, B. Pintado, J. M. Sánchez-Morgado, B. Whitelaw, J. Clark, and L. Enjuanes. High level expression of enteric coronavirus neutralizing antibody in the milk of transgenic mice using the cDNA encoding chimeric IgA under β-lactoglobulin promoter. Submitted for publication.
40. Staats, H. F., R. J. Jackson, M. Marinaro, I. Takahashi, H. Kiyono, and J. R. McGhee. 1994. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immunol. 6:572-583.
41. Stone, S. S., L. J. Kemeny, R. D. Woods, and M. T. Jensen. 1977. Efficacy of isolated colostral IgA, IgG, and IgM(A) to protect neonatal pigs against the coronavirus transmissible gastroenteritis. Am. J. Vet. Res. 38:1285-1288.
42. Suñé, C., G. Jiménez, I. Correa, M. J. Bullido, F. Gebauer, C. Smerdou, and L. Enjuanes. 1990. Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology 177:559-569.
43. Taylor, H. P., and N. J. Dimmock. 1985. Mechanism of neutralization of influenza-virus by secretory IgA is different from that of monomeric IgA or IgG. J. Exp. Med. 161:198-209.
44. Torres, J. M., C. Alonso, A. Ortega, S. Mittal, F. Graham, and L. Enjuanes. 1996. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol. 70:3770-3780.
45. Torres, J. M., C. Sanchez, C. Suñé, C. Smerdou, L. Prevec, F. Graham, and L. Enjuanes. 1995. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213:503-516.
46. VanCott, J. L., T. A. Brim, R. A. Simkins, and L. J. Saif. 1993. Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut-and bronchus-associated lymphoid tissues of suckling pigs. J. Immunol. 150:3990-4000.
47. Weidle, U. H., A. Borgya, R. Mattes, H. Lenz, and P. Buckel. 1987. Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells. Gene 51:21-29.
48. Weidle, U. H., S. Koch, and P. Buckel. 1987. Expression of antibody cDNA in murine myeloma cells: possible involvement of additional regulatory elements in transcription of immunoglobulin genes. Gene 60:205-216.
49. Wesley, R. D., and R. D. Woods. 1993. Immunization of pregnant gilts with PRCV induces lactogenic immunity for protection of nursing piglets from challenge with TGEV. Vet. Microbiol. 38:31-40.
50. Xoma Co. May 1987. Patent WO 87/02671.